3/28/2025 7:15:47 PM USPTO Issues Significant Changes to Post-Grant Patent Review Procedures By Jonathan B. Thielbar This week, the U.S. Patent and Trademark Office (USPTO) issued a memorandum introducing new processes related to discretionary denials of...
3/27/2025 6:37:35 PM Introducing The Sports Law Playbook: Q1 2025 By Brian R. Socolow Alexander Loh Derek Crownover Scott Zolke +1 more... Show less Welcome to the inaugural issue of The Sports Law Playbook, Loeb & Loeb’s quarterly update bringing you the latest legal developments in...
3/3/2025 8:23:20 PM USPTO Rescinds PTAB Denial Guidelines By William J. Kramer This morning, in a likely pro-patent holder approach, the U.S. Patent and Trademark Office (USPTO) rescinded a guidance memorandum from...
2/19/2025 6:32:40 PM The Landscape of Regeneron’s Eylea® Litigation After the Federal Circuit Affirmed Two Preliminary Injunction Orders Blocking Biosimilar Market Entry By Dan Liu A biosimilar is a biologic drug that is highly similar, but not identical, to an already approved biologic drug, i.e. the reference...
8/21/2024 7:43:24 PM Allergan Holding Protects "First-Filed" Parent Patents from Their Misbehaving Patent Offspring By Jonathan B. Thielbar This month, in Allergan USA, Inc. v. MSN Laboratories Private Ltd., the Federal Circuit added to the ongoing patent-family drama...
5/21/2024 5:19:50 PM USPTO's Proposed New Terminal Disclaimer Rule Would Change Applicant and Patent Challenger Strategy By Jonathan B. Thielbar The United States Patent and Trademark Office (USPTO) has proposed changes to terminal disclaimer rules that could significantly...
5/14/2024 10:10:17 PM GSK Joins COVID-19 mRNA Vaccine Patent War By Dan Liu mRNA-Based Vaccine and Other Therapeutics mRNA-based vaccines have become one of the most discussed technologies both inside and outside...
5/3/2024 7:51:05 PM Will AI-Generated Prior Art Ruin the Patent System? The USPTO Wants to Hear from You. By Jonathan B. Thielbar Earlier this week, the U.S. Patent and Trademark Office (USPTO) issued a request for public comment regarding the impact of artificial...
4/30/2024 9:28:13 PM Appeals Court Signals Narrowing of Fair Use Doctrine Post-Warhol By Frank D. D'Angelo Copyright attorneys eagerly anticipated the U.S. Supreme Court's fair use opinion in Andy Warhol Foundation for the Visual Arts, Inc. v....
4/25/2024 9:24:10 PM Amending ANDA by Purportedly Carving Out Infringing Use—After Trial—Does Not Rescue the Amended ANDA from the Negative PIV Judgment By Dan Liu The district court in Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc., Civil Action No. 20-430-RGA (D. Del.) was asked...
4/11/2024 9:37:17 PM AI Cannot (Yet) File Your Trademark Applications By Melanie J. Howard The U.S. Patent & Trademark Office (USPTO) has issued new guidance affirming that its existing rules regarding user accounts, access to...
3/28/2024 8:06:03 PM Reminder: Motivation to Combine Is Still Required to Render Patent Claims Obvious By Jonathan B. Thielbar The Federal Circuit recently reversed a PTAB obviousness finding because it found no motivation to combine features of the two cited...